Rat Model Market Growth Opportunities: Insights from 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Rat Model Industry Compare Between 2025 And 2029?

The market valuation for rat models has experienced substantial expansion lately, projected to escalate from $1.65 billion in the year 2024 to reach $1.75 billion by 2025, reflecting a compound annual growth rate (CAGR) of 6.6%; this upward trajectory during the historical timeframe is sustained by augmenting requirements for preclinical investigations, elevated levels of public sector financial support, escalating research needs, various drug development efforts, and the prevalence of persistent illnesses.

Projections indicate robust expansion for the market utilizing rat models over the approaching years, with the valuation set to reach $2.54 billion by 2029, signifying a compound annual growth rate of 9.7%; this anticipated increase is underpinned by several factors, such as the widening use in tailor-made medical therapies, the escalating need for animal subjects in pharmaceutical development, a heightened emphasis on averting illnesses, the proliferation of the biopharmaceutical sector, progress in imaging methods, and substantial backing from both governmental and private sources, while key movements shaping this timeframe encompass worldwide research partnerships, sophisticated developments in imaging technology, the incorporation of omics-based sciences, forward strides in gene modification processes, the increasing significance of rat subjects within pathology studies, and the ascendancy of personalized medicine approaches coupled with bespoke rat models.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10100&type=smp

Which Drivers Are Shaping The Rat Model Industry’s Market Share?

Anticipation surrounds the rat model sector’s expansion, fueled by the increasing prevalence of long-term illnesses, which are defined as ailments persisting for more than a year, frequently impeding daily functioning and necessitating ongoing medical attention, or both. These rat models have proven essential in dissecting the development, immunological reactions, and therapeutic avenues for persistent infections, yielding crucial knowledge to guide the creation of novel treatments and interventions; for illustration, data from the World Health Organization, a UN specialized body based in Switzerland, indicated in September 2023 that non-communicable diseases (NCDs), or chronic conditions, were responsible for an estimated 41 million yearly fatalities worldwide, constituting 74% of all deaths, thus establishing the escalating rate of chronic diseases as a primary catalyst for the rat model market’s upward trajectory.

How Is The Rat Model Market Classified Into Different Segments?

The rat modelmarket covered in this report is segmented –

1) By Type: Knockout, Outbred, Inbred, Hybrid, Immunodeficient, Conditioned

2) By Service: Cryopreservation, Breeding, Re-derivation, Genetic Testing, Quarantine Depending, Other Services

3) By Technology: Nuclear Transferase, Microinjection, Embryonic Stem Cell, Other Technologies

4) By Application: Oncology, Neurology, Immunology, Toxicology, Other Applications

Subsegments:

1) By Knockout: CRISPR Knockout, Traditional Knockout

2) By Outbred: Sprague Dawley, Long-Evans, Wistar

3) By Inbred: Fischer 344, Lewis, Buffalo

4) By Hybrid: F1 Hybrid, F2 Hybrid

5) By Immunodeficient: Nude Rats, SCID Rats

6) By Conditioned: Obese Rats, Diabetic Rats

What Long-Term Trends Will Shape The Future Growth Of The Rat Model Industry?

Leading corporations within the rat model sector are forging alliances strategically to advance preclinical investigations spanning oncology and diverse medical fields. By joining forces with entities specializing in rat model provision, these major players can concentrate resources on their primary operations, effectively harnessing the streamlined processes and economic benefits offered by these expert suppliers who possess ready infrastructure and capacity for developing requisite rat models. Illustratively, in the third month of 2022, the American biotech firm Hera BioLabs entered into an agreement with Charles River Laboratories, International Inc., another US-based pharmaceutical entity, to manage the market rollout of Hera’s SRG rat, commonly referred to as OncoRat. This pact designates Charles River as the entity responsible for the reproduction, dissemination, sale, and promotion of the SRG rat directly to those involved in preclinical investigation. Because the SRG rat exhibits profound immunodeficiency, it presents itself as an excellent candidate for both xenograft investigations and patient-derived xenograft (PDX) studies, offering distinct superiority over conventional mouse models when assessing the in vivo effectiveness of novel cancer treatments. This particular model circumvents the constraints associated with smaller murine counterparts, facilitating the achievement of greater tumor mass, simplifying surgical procedures, and yielding greater quantities of tissue and serum amenable to comprehensive analysis, even permitting serial collection of samples.

Who Are The Major Companies Operating In The Rat Model Market?

Major companies operating in the rat model market include Genoway S.A., Biomere, Transposagen Biopharmaceuticals Inc., Horizon Discovery Group PLC, Transviragen Inc., Charles River Laboratories International Inc., Taconic Biosciences Inc., Envigo Ltd., Laboratory Corporation of America Holdings, Janvier Labs, Harlan Laboratories Inc., Sage Path Labs, Applied StemCell Inc., Regenera Pharma Ltd., Cyagen Biosciences Inc., Ozgene Pty Ltd, Yecuris Corporation, Hera BioLabs Inc., Beijing Biocytogen Co. Ltd., Ingenious Targeting Laboratory, InVivos Pte Ltd., Kymab Limited, Mirimus Inc., Pharmaron Beijing Co. Ltd., PolyGene AG, Shanghai Model Organisms Center Inc., Sino Biological Inc., Synthego Corporation, Transgenic Inc., ViGene Biosciences Inc., Viva Biotech Holdings, WuXi AppTec Co. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/rat-model-global-market-report

What Regional Growth Trends Are Shaping The Rat Model Market Outlook?

North America was the largest region in the rat model market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global rat model market report during the forecast period. The regions covered in the rat model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Rat Model Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10100&type=smp

Browse Through More Reports Similar to the Global Rat Model Market 2025, By The Business Research Company

Protein Expression Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report

Insecticides Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/insecticides-global-market-report

Pesticide And Other Agricultural Chemicals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pesticide-and-other-agricultural-chemicals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795